12.2 The WHO International Code of Marketing of Breastmilk Substitutes

Why This Topic Matters for the CLC Exam

General Principle II and Step 1a of the BFHI both point back to a single document: the WHO International Code of Marketing of Breast-milk Substitutes (commonly called “the WHO Code” or just “the Code”). The ALPP blueprint expects a CLC to recognize Code-violating marketing materials in the field — a free formula sample in a hospital discharge bag, a poster in a clinic showing a smiling baby on a formula can, a company representative offering to “educate” new mothers directly. The exam is far more likely to give you a scenario to judge than to ask you to recite the Code's history, so understanding what the Code actually prohibits is the highest-yield preparation here.

Origin and Legal Status

The Code was adopted by the World Health Assembly (WHA) — the governing body of WHO — in 1981, following documented concerns that aggressive formula marketing in low-resource settings was contributing to unsafe bottle-feeding (mixed with contaminated water, over-diluted to stretch supply) and declining breastfeeding rates. Importantly, the Code is a set of minimum recommendations adopted by consensus, not a treaty that is automatically enforceable. Its actual legal force depends on national legislation: some countries have adopted the Code (and later WHA resolutions strengthening it) into binding law with penalties, others have adopted only parts of it, and some countries — including the United States — have not enacted the full Code into federal law, though individual healthcare systems and Baby-Friendly facilities voluntarily comply with it as a condition of BFHI designation.

What Products Are Covered

The Code applies to any product marketed or represented as suitable for partial or total replacement of breast milk, including:

• Infant formula
• Follow-up/toddler formulas and other breast-milk-substitute products
• Bottle-fed complementary foods marketed for infants under 6 months
• Feeding bottles and teats (artificial nipples)

Subsequent WHA resolutions extended the scope of restricted marketing to cover products intended for infants and young children up to 3 years of age, closing a loophole where companies had shifted aggressive marketing tactics to “toddler milks” and follow-on formulas not explicitly named in the original 1981 text.

Core Prohibitions — What a CLC Should Be Able to Recognize

Educational materials about infant feeding that are distributed to families should be objective, scientifically accurate, and free of brand references — they should not display a company logo or product name, and should always mention the superiority of breastfeeding and the costs/risks of not breastfeeding alongside safe preparation information for whenever formula is used.

What the Code Does NOT Do

A frequent misunderstanding — and a realistic exam distractor — is that the Code bans formula or tells parents they cannot formula-feed. It does not. The Code regulates marketing practices, not a family's right to choose or a company's right to sell the product through normal, non-promotional retail channels. A CLC counseling a mother who has made an informed decision to formula-feed should still provide safe preparation and paced-bottle-feeding guidance without judgment — that is an ethics point (see Chapter 13), while the Code is squarely about restraining commercial promotion, not clinical practice or parental choice.

Monitoring and Reporting Violations

The International Baby Food Action Network (IBFAN), through its International Code Documentation Centre, is the primary independent watchdog that monitors global Code compliance and periodically publishes “Breaking the Rules, Stretching the Rules” reports documenting violations by country and company. When a CLC identifies a likely violation — for example, a formula company representative attempting to give free samples directly to patients on a unit — the appropriate action per the ALPP Code of Ethics is to document and report the violation through the facility's compliance channel or to IBFAN/relevant national authority, not to personally confront the representative or escalate outside their scope of practice.

Exam Scenario Walkthrough

A CLC working in a pediatric clinic notices a formula company representative has left a stack of branded tote bags containing formula samples and a company-branded feeding chart at the front desk for parents to take. This scenario violates at least two Code provisions at once: free samples to mothers/families, and educational-looking material that carries a brand name rather than being neutral. The correct CLC response is to flag this to clinic management/compliance for removal and reporting — not to hand the bags out, and not to ignore it because “it's not a hospital.” The Code applies to health facilities broadly, not only birthing hospitals.